The biopharmaceutical startups space is changing, Hannah
But is your CRM data an asset or a liability in finding clients like Spark Advisors and Polimorphic?
But is your CRM data an asset or a liability in finding clients like Spark Advisors and Polimorphic?
Most CRMs are a mess — full of outdated, messy, and duplicated data.
We clean it up.
Using Clay, AI, and custom rules, we enrich your records with precision.
The result?
Smarter segmentation, faster lead routing, and a CRM your team can finally trust.
No more guesswork. Just clean, accurate data.
Only a handful of sales leaders are using automated CRM enrichment. But those who do are getting a serious edge.
To help you explore how it might support your workflow, here are a few questions:
1️⃣ How do you currently identify which biopharmaceutical startups are most aligned with your clinical development offerings? 2️⃣ What challenges do you face in understanding the decision-making process for your clients’ clinical trial budgets? 3️⃣ When assessing a potential partnership, how effectively can you segment opportunities based on their unique regulatory needs?
If you’re ready for a CRM that works for you, not against you, let’s talk.
The form has been successfully submitted.